Return On Equity of Turnstone Biologics Corp. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Turnstone Biologics Corp. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2022 to 30 Jun 2025.
  • Turnstone Biologics Corp. Return On Equity for the quarter ending 30 Jun 2025 was -172%, a 103% decline year-over-year.
  • Turnstone Biologics Corp. annual Return On Equity for 2024 was -132%, a 105% decline from 2023.
  • Turnstone Biologics Corp. annual Return On Equity for 2023 was 2672%, a 7704% increase from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Turnstone Biologics Corp. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2025 -172% -87% -103% 01 Apr 2025 30 Jun 2025
Q1 2025 -163% +11% +6.6% 01 Jan 2025 31 Mar 2025
Q4 2024 -132% -2804% -105% 01 Oct 2024 31 Dec 2024
Q3 2024 -106% -206% -205% 01 Jul 2024 30 Sep 2024
Q2 2024 -85% -135% -271% 01 Apr 2024 30 Jun 2024
Q1 2024 -174% -194% -980% 01 Jan 2024 31 Mar 2024
Q4 2023 2672% +2638% +7704% 01 Oct 2023 31 Dec 2023
Q3 2023 101% 01 Jul 2023 30 Sep 2023
Q2 2023 50% 01 Apr 2023 30 Jun 2023
Q1 2023 20% 01 Jan 2023 31 Mar 2023
Q4 2022 34% 01 Oct 2022 31 Dec 2022

Turnstone Biologics Corp. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -132% -2804% -105% 01 Jan 2024 31 Dec 2024
2023 2672% +2638% +7704% 01 Jan 2023 31 Dec 2023
2022 34% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.